- Publisher Correction
- Open access
- Published:
Publisher Correction: Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy
Journal of Nanobiotechnology volume 22, Article number: 288 (2024)
The Original Article was published on 15 April 2024
Correction: Journal of Nanobiotechnology (2024) 22:184
Following publication of the original article details for affiliations of all authors were incorrectly given as:
1. Department of Biomedical and Clinical Sciences, Università di Milano, 20157 Milan, Italy.
2. Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Rafaele Scientifc Institute, Milan, Italy.
3. Istituti Clinici, Scientifci Maugeri IRCCS, 27100 Pavia, Italy.
4. Laboratory of Supramolecular and Bio-Nanomaterials (SBNLab), Department of Chemistry, Materials, and Chemical Engineering “Giulio Natta”, Politecnico di Milano, 20131 Milan, Italy.
But should have been:
1. Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan 20157, Italy.
2. Istituti Clinici Scientifici Maugeri IRCCS, Pavia 27100, Italy.
3. Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
4. Laboratory of Supramolecular and Bio-Nanomaterials (SBNLab), Department of Chemistry, Materials, and Chemical Engineering “Giulio Natta”, Politecnico di Milano, Milano 20131, Italy.
The original article has been updated.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12951-024-02441-4.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Sevieri, M., Andreata, F., Mainini, F. et al. Publisher Correction: Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy. J Nanobiotechnol 22, 288 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12951-024-02532-2
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12951-024-02532-2